| 1 |
35353990 | Expression of arylamine N-acetyltransferase 2 activity in immortalized human bronchial epithelial cells. | 2022 May 1 |
1 |
| 2 |
33094670 | Arylamine N-acetyltransferase acetylation polymorphisms: paradigm for pharmacogenomic-guided therapy- a focused review. | 2021 Jan |
1 |
| 3 |
33815485 | Functional Characterization of the Effects of N-acetyltransferase 2 Alleles on N-acetylation of Eight Drugs and Worldwide Distribution of Substrate-Specific Diversity. | 2021 |
4 |
| 4 |
32372066 | Human arylamine N-acetyltransferase 2 genotype-dependent protein expression in cryopreserved human hepatocytes. | 2020 May 5 |
3 |
| 5 |
30358977 | Molecular and Functional Characterization of N-Acetyltransferases NAT1 and NAT2 in Cynomolgus Macaque. | 2018 Nov 19 |
1 |
| 6 |
28516247 | Genetic heterogeneity among slow acetylator N-acetyltransferase 2 phenotypes in cryopreserved human hepatocytes. | 2017 Jul |
5 |
| 7 |
28523442 | Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype. | 2017 Aug |
10 |
| 8 |
26519524 | Effect of acetaminophen on sulfamethazine acetylation in male volunteers. | 2016 Mar |
3 |
| 9 |
24013186 | N-acetylation of etamicastat, a reversible dopamine-β-hydroxylase inhibitor. | 2013 Dec |
1 |
| 10 |
21317369 | Liver-selective expression of human arylamine N-acetyltransferase NAT2 in transgenic mice. | 2011 May |
6 |
| 11 |
21946899 | Acetylator status and N-acetyltransferase 2 gene polymorphisms; phenotype-genotype correlation with the sulfamethazine test. | 2011 Dec |
1 |
| 12 |
19336229 | Estimating N-acetyltransferase metabolic activity and pharmacokinetic parameters of isoniazid from genotypes in Chinese subjects. | 2009 Jul |
1 |
| 13 |
18852012 | Arylamine N-acetyltransferases: structural and functional implications of polymorphisms. | 2008 Dec 30 |
2 |
| 14 |
16507510 | Inhibitory effects of polyphenolic compounds on human arylamine N-acetyltransferase 1 and 2. | 2006 Jan |
1 |
| 15 |
15843491 | Identification of cytochrome P450 and arylamine N-acetyltransferase isoforms involved in sulfadiazine metabolism. | 2005 Jul |
1 |
| 16 |
15880531 | Expression of cytochromes P450 and glutathione S-transferases in human prostate, and the potential for activation of heterocyclic amine carcinogens via acetyl-coA-, PAPS- and ATP-dependent pathways. | 2005 Oct 20 |
1 |
| 17 |
15930747 | Interindividual variability in 5-Fluorouracil metabolism and procainamide N-acetylation in human liver cytosol. | 2005 Jun |
1 |
| 18 |
15334622 | Acetylation phenotype status in a Bangladeshi population and its comparison with that of other Asian population data. | 2004 Sep |
1 |
| 19 |
14503661 | Pharmacokinetics of a novel N-methyl-D-aspartate receptor antagonist (SM-18400): identification of an N-acetylated metabolite and pre-clinical assessment of N-acetylation polymorphism. | 2003 Jan-Mar |
2 |
| 20 |
12222688 | Functional genomics of C190T single nucleotide polymorphism in human N-acetyltransferase 2. | 2002 Jun |
2 |
| 21 |
11337936 | Functional characterization of human N-acetyltransferase 2 (NAT2) single nucleotide polymorphisms. | 2001 Apr |
1 |
| 22 |
11478689 | Arylamine N-acetyltransferase activities in human breast cancer tissues. | 2001 |
1 |
| 23 |
10692486 | Substrate-dependent regulation of human arylamine N-acetyltransferase-1 in cultured cells. | 2000 Mar |
1 |
| 24 |
10794727 | Identification of amino acids imparting acceptor substrate selectivity to human arylamine acetyltransferases NAT1 and NAT2. | 2000 May 15 |
4 |
| 25 |
9823980 | Expression in human prostate of drug- and carcinogen-metabolizing enzymes: association with prostate cancer risk. | 1998 Nov |
1 |
| 26 |
9241664 | Relationship between human genotype and phenotype of N-acetyltransferase (NAT2) as estimated by discriminant analysis and multiple linear regression: 1. Genotype and N-acetylation in vivo. | 1997 Jun |
1 |
| 27 |
8866914 | Caffeine as a metabolic probe: NAT2 phenotyping. | 1996 Mar |
3 |
| 28 |
9156694 | Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlations. | 1996 Apr |
1 |
| 29 |
7669073 | Enzyme kinetic properties of human recombinant arylamine N-acetyltransferase 2 allotypic variants expressed in Escherichia coli. | 1995 Aug 25 |
2 |
| 30 |
7889851 | Polymorphism of human acetyltransferases. | 1994 Oct |
1 |
| 31 |
7995004 | Polymorphic arylamine N-acetyltransferase (NAT2) genes in children with insulin-dependent diabetes mellitus. | 1994 Dec |
2 |
| 32 |
1306121 | Genotyping human polymorphic arylamine N-acetyltransferase: identification of new slow allotypic variants. | 1992 Oct |
2 |
| 33 |
1441598 | Polymorphisms of N-acetyltransferase genes. | 1992 Sep-Oct |
1 |
| 34 |
1762071 | Expression of monomorphic arylamine N-acetyltransferase (NAT1) in human leukocytes. | 1991 Dec |
1 |
| 35 |
1872889 | N-acetyltransferase polymorphism. Comparison of phenotype and genotype in humans. | 1991 Aug 8 |
2 |
| 36 |
1996083 | Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. | 1991 Feb |
2 |
| 37 |
2924904 | Evidence for two closely related isozymes of arylamine N-acetyltransferase in human liver. | 1989 Feb 13 |
1 |